These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 17389382

  • 1. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.
    Proc Natl Acad Sci U S A; 2007 Apr 10; 104(15):6335-40. PubMed ID: 17389382
    [Abstract] [Full Text] [Related]

  • 2. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G, Han G, Wang J, Wang R, Xu R, Shen B, Qian J, Li Y.
    J Leukoc Biol; 2008 Feb 10; 83(2):280-7. PubMed ID: 18029395
    [Abstract] [Full Text] [Related]

  • 3. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973
    [Abstract] [Full Text] [Related]

  • 4. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L.
    Novartis Found Symp; 2003 Jan 27; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
    Belghith M, Bluestone JA, Barriot S, Mégret J, Bach JF, Chatenoud L.
    Nat Med; 2003 Sep 27; 9(9):1202-8. PubMed ID: 12937416
    [Abstract] [Full Text] [Related]

  • 7. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B.
    Gene Ther; 2004 Oct 27; 11(20):1487-96. PubMed ID: 15343360
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug 27; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 9. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
    Liu Y, Amarnath S, Chen W.
    Transplantation; 2006 Oct 15; 82(7):953-64. PubMed ID: 17038912
    [Abstract] [Full Text] [Related]

  • 10. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.
    Diabetes; 2007 May 15; 56(5):1395-402. PubMed ID: 17317763
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
    Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A.
    Vaccine; 2006 Jun 05; 24(23):5036-46. PubMed ID: 16621191
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice.
    Xia J, Liu W, Hu B, Tian Z, Yang Y.
    Clin Immunol; 2010 Feb 05; 134(2):130-9. PubMed ID: 19875339
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
    Zhang X, Reddy J, Ochi H, Frenkel D, Kuchroo VK, Weiner HL.
    Int Immunol; 2006 Apr 05; 18(4):495-503. PubMed ID: 16540527
    [Abstract] [Full Text] [Related]

  • 18. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.
    Diabetes; 2008 Jan 05; 57(1):113-23. PubMed ID: 17928397
    [Abstract] [Full Text] [Related]

  • 19. Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.
    Richer MJ, Straka N, Fang D, Shanina I, Horwitz MS.
    Diabetes; 2008 May 05; 57(5):1302-11. PubMed ID: 18268045
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.
    Wang R, Song L, Han G, Wang J, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y.
    Scand J Immunol; 2007 Nov 05; 66(5):515-22. PubMed ID: 17883389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.